Researchers at the University of Michigan Health Rogel Cancer Centre have discovered a mechanism that causes important gastrointestinal difficulties during immune-based cancer treatment.
According to the Brigham researchers' next-generation sequencing, changing existing cancer care standards might allow around 6,000 more patients in the United States to benefit from immunotherapy treatment each year.
A group led by scientists at The University of Texas at Austin has discovered a brand-new, bio-inspired medication that restores the capability of immune cells to combat cancer. The medication increases the effectiveness of immunotherapy and inhibits tumour growth in mice models of melanoma,
A study performed by UCLA Jonsson Comprehensive Cancer Centre researchers gave new light on why tumours that have spread to the brain from other parts of the body react to immunotherapy whereas glioblastoma, an aggressive brain cancer, does not.
According to recent research published in the Journal of Experimental Medicine, equipping cancer-infecting viruses with tumor-inhibiting genetic cargo boosts the immune system and supports immunotherapy in reducing or totally eradicating aggressive tumours in mice. The findings pave the path
According to a new study published in the Journal of Experimental Medicine, equipping cancer-infecting viruses with tumour-inhibiting genetic cargo promotes the immune system and aids immunotherapy in shrinking or completely clearing aggressive tumours in mice. The findings pave the way f
Glioblastoma, the most prevalent and lethal type of brain cancer, spreads quickly, invading and destroying healthy brain tissue. The tumour shoots malignant tendrils into the brain, making surgical removal of the tumour extremely difficult or impossible.
Researchers have discovered a protein that is crucial to the operation of numerous novel cancer medicines. The discovery, according to the researchers, will probably help with efforts to optimize the use of immunotherapies against a number of difficult tumors.
The cancer immunotherapy atezolizumab1 significantly increased the overall survival of patients with advanced stage non-small cell lung cancer who were unable to receive platinum-containing chemotherapy when compared to single-agent chemotherapy, according to a global study conducted by UCL
Immunotherapy is one of the most recent and effective cancer treatments. It causes the immune system to identify tumours as intruders in the body and attack them. However, not all patients benefit from immunotherapy. Why? Scientists are not always sure.
Ultrasound is a potential cancer treatment tool. Unlike laser light, which is employed in photodynamic cancer therapy, ultrasonic waves may penetrate deep into tissue (up to 12 cm) to treat deep tumours while causing no harm to healthy cells.
A new study provided a deeper understanding of the vast diversity of T cell states, as well as their relationships and roles within the complex tumour microenvironment, bringing a new perspective to understanding immunotherapy efficacy in cancer.